<DOC>
	<DOC>NCT01007123</DOC>
	<brief_summary>The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.</brief_summary>
	<brief_title>Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Patient meets protocol specified criteria for constipation Patient has successfully completed study requirements with no clinically relevant findings for physical exam, ECG, laboratory tests and colonoscopy as applicable Medical history or medical condition that would not make the patient a good candidate for the study or limit the patientÂ´s ability to complete the study Patient reports loose stools Patient has IBS with pain/discomfort as predominant symptom Patient needs medications prohibited as specified in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Chronic idiopathic constipation</keyword>
	<keyword>A3309</keyword>
</DOC>